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Worldwide, an emerging increase in antimicrobial resistance is observed. This is alarming since 
antimicrobial resistance might not only be responsible for increased morbidity and mortality for 
the individual patient, but has also been responsible for major hospital outbreaks. 
The aim of this research was to study different strategies and methods to improve the 
laboratory detection of highly resistant micro-organisms (HRMOs) and at the same time decrease 
the time to result.  The rapid and correct detection of HRMOs is of utmost importance for the 
individual patient, in order to obtain the adequate treatment as rapid as possible. Moreover, the 
improved laboratory detection of HRMOs is important for the implementation of the correct 
infection prevention measures within hospitals. 
The results of the research in chapter 2 showed that phenotypical detection of extended-
spectrum beta-lactamases (ESBLs) can produce false positive results, compared to the molecular 
detection of ESBL. Since the current Dutch guideline recommends to nurse ESBL positive 
patients in isolation, these false positive results can consequently be responsible for installing 
incorrect isolation procedures. Next to the additional costs associated with isolated nursing, it is 
also very inconvenient and stressful for both patient and nursing personnel. Therefore, the use 
of molecular detection to confirm ESBL suspected isolates is important to prevent unnecessary 
costs and frustration associated with incorrect isolation procedures.
All studies presented in this thesis, describe a molecular method that is responsible for a 
reduction in time to result, when compared to conventional phenotypical methods. This 
reduction in time to result is important to prevent further spread of HRMOs within the hospital, 
since corresponding infection prevention measures can be installed earlier. Moreover, when an 
accidental HRMO is identified from a sample obtained from a hospitalized patient, molecular 
methods as described in this thesis can be used in order to rapidly generate an overview on the 
possible spread of the corresponding HRMO. Both the early prevention of further spread of 
multi-resistant bacteria and the possibility to avoid unnecessary isolation days (because of the 
rapid detection of HRMOs) will save hospitals a high amount of money. Consequently, this saved 
money can be used elsewhere in the hospital for further improvement of healthcare. 
Eventually, when molecular methods as described in this thesis are widely introduced, 
the rapid and correct detection of HRMOs and the consequences as described above will be 
responsible for reducing worldwide spread of HRMOs, which is one of the focus points of the 
World Health Organization (WHO). This reduction in worldwide spread of HRMOs hopefully 
gives time for the development of new antimicrobial agents to treat the current HRMOs.
The results reported in this thesis are of considerable interest to clinical microbiologists, 
molecular biologists and infection prevention workers. Moreover, the results can also be 
helpful to policymakers. The current Dutch guideline for the laboratory detection of HRMOs, as 
developed by a working group of the Dutch society for medical microbiology (NVMM), describes 
recommendations that are mainly based on conventional phenotypical methods.  With the 
results of the research as presented in this thesis, new insights on the genotypic detection of 
HRMOs are obtained. These insights can be used when the current guideline for the laboratory 
detection of HRMOs is revised.  
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In the past decade, a number of different techniques, developed by different researchers or 
companies, have been introduced for the laboratory detection of HRMOs. The results of the 
research as described in this thesis will provide a solid basis for near future molecular diagnostic 
assays as well as for improvement of currently available methods. In chapter 3, we describe 
the distribution of ESBL genes found in the east of the Netherlands. The results of this study, 
combined with other studies, will be important to companies that develop molecular assays 
for the rapid detection of ESBL genes. The scientific evidence described in this thesis and other 
studies will enable companies to make decisions on the relevant genes that have to be included 
into a new assay. The same holds true for the results of chapters 4 and 5, in which respectively 
the different types of MRSA and CPE are described that have been identified with our routine 
screening method. 
During the studies performed for this thesis, a wide variety of clinical isolates have been 
analyzed. These clinical isolates are stored and included in the corresponding collection and 
database of the Laboratory for Medical Microbiology and Medical Immunology. Since the 
presence and type of resistance-genes in these clinical isolates is well known, this collection can 
be very valuable for future studies and validation of (commercial) molecular diagnostic assays. 
The results of such validations can both be used for publications in peer reviewed journals, as 
well as for CE marking of products.
To conclude, the prevalence of antibiotic resistance is increasing, resulting in a worldwide 
spread of these highly resistant micro-organisms. This thesis described evaluations and 
implementations of molecular methods for the correct and rapid detection of HRMOs. These 
methods can therefore contribute to the prevention of further spread of HRMOs, resulting in 
time needed to develop new antimicrobial agents to be used for the treatment of infections 
caused by the HRMOs.
